Renal transplantation at the University of Michigan 1964 to 1999.

J. C. Magee, R. S. Sung, J. G. Turcotte, J. D. Punch, A. O. Ojo, D. M. Cibrik, J. W. Konnak, D. A. Bloom, J. S. Wolf, B. Kaplan, S. M. Rudich, T. E. Bunchman, A. B. Leichtman, R. M. Merion, D. A. Campbell

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Michigan Kidney Transplant Program has existed for 35 years. Outcomes have improved dramatically as the one-year survival of cadaver kidney grafts increased from 25% to 85-90%. Patient deaths in the first year are now uncommon. Indications for renal transplantation have been extended to infants, the elderly, diabetics and to patients with other significant health problems who would not have been candidates in the past. Chronic administration of large doses of corticosteroids is no longer necessary and the associated morbidity is largely avoided. Improvements in immunosuppression, especially the introduction of cyclosporine, account for much of this progress. With success has come increasing demand. Unfortunately, the gap between the number of available donor kidneys and the number of patients listed for a cadaver transplant continues to increase rather than diminish. Greater acceptance of volunteer donation, as has occurred in our own program, will help to reduce this shortage. If the past forecasts the future, we can anticipate extraordinary advances during the next 35 years.

Original languageEnglish (US)
Pages (from-to)139-148
Number of pages10
JournalClinical transplants
StatePublished - 1999
Externally publishedYes

Fingerprint

Kidney Transplantation
Transplants
Kidney
Cadaver
Immunosuppression
Cyclosporine
Volunteers
Adrenal Cortex Hormones
Tissue Donors
Morbidity
Survival
Health

Cite this

Magee, J. C., Sung, R. S., Turcotte, J. G., Punch, J. D., Ojo, A. O., Cibrik, D. M., ... Campbell, D. A. (1999). Renal transplantation at the University of Michigan 1964 to 1999. Clinical transplants, 139-148.

Renal transplantation at the University of Michigan 1964 to 1999. / Magee, J. C.; Sung, R. S.; Turcotte, J. G.; Punch, J. D.; Ojo, A. O.; Cibrik, D. M.; Konnak, J. W.; Bloom, D. A.; Wolf, J. S.; Kaplan, B.; Rudich, S. M.; Bunchman, T. E.; Leichtman, A. B.; Merion, R. M.; Campbell, D. A.

In: Clinical transplants, 1999, p. 139-148.

Research output: Contribution to journalArticle

Magee, JC, Sung, RS, Turcotte, JG, Punch, JD, Ojo, AO, Cibrik, DM, Konnak, JW, Bloom, DA, Wolf, JS, Kaplan, B, Rudich, SM, Bunchman, TE, Leichtman, AB, Merion, RM & Campbell, DA 1999, 'Renal transplantation at the University of Michigan 1964 to 1999.', Clinical transplants, pp. 139-148.
Magee JC, Sung RS, Turcotte JG, Punch JD, Ojo AO, Cibrik DM et al. Renal transplantation at the University of Michigan 1964 to 1999. Clinical transplants. 1999;139-148.
Magee, J. C. ; Sung, R. S. ; Turcotte, J. G. ; Punch, J. D. ; Ojo, A. O. ; Cibrik, D. M. ; Konnak, J. W. ; Bloom, D. A. ; Wolf, J. S. ; Kaplan, B. ; Rudich, S. M. ; Bunchman, T. E. ; Leichtman, A. B. ; Merion, R. M. ; Campbell, D. A. / Renal transplantation at the University of Michigan 1964 to 1999. In: Clinical transplants. 1999 ; pp. 139-148.
@article{60d05e5e805d49f7ae8fbb19df3b291a,
title = "Renal transplantation at the University of Michigan 1964 to 1999.",
abstract = "The Michigan Kidney Transplant Program has existed for 35 years. Outcomes have improved dramatically as the one-year survival of cadaver kidney grafts increased from 25{\%} to 85-90{\%}. Patient deaths in the first year are now uncommon. Indications for renal transplantation have been extended to infants, the elderly, diabetics and to patients with other significant health problems who would not have been candidates in the past. Chronic administration of large doses of corticosteroids is no longer necessary and the associated morbidity is largely avoided. Improvements in immunosuppression, especially the introduction of cyclosporine, account for much of this progress. With success has come increasing demand. Unfortunately, the gap between the number of available donor kidneys and the number of patients listed for a cadaver transplant continues to increase rather than diminish. Greater acceptance of volunteer donation, as has occurred in our own program, will help to reduce this shortage. If the past forecasts the future, we can anticipate extraordinary advances during the next 35 years.",
author = "Magee, {J. C.} and Sung, {R. S.} and Turcotte, {J. G.} and Punch, {J. D.} and Ojo, {A. O.} and Cibrik, {D. M.} and Konnak, {J. W.} and Bloom, {D. A.} and Wolf, {J. S.} and B. Kaplan and Rudich, {S. M.} and Bunchman, {T. E.} and Leichtman, {A. B.} and Merion, {R. M.} and Campbell, {D. A.}",
year = "1999",
language = "English (US)",
pages = "139--148",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Renal transplantation at the University of Michigan 1964 to 1999.

AU - Magee, J. C.

AU - Sung, R. S.

AU - Turcotte, J. G.

AU - Punch, J. D.

AU - Ojo, A. O.

AU - Cibrik, D. M.

AU - Konnak, J. W.

AU - Bloom, D. A.

AU - Wolf, J. S.

AU - Kaplan, B.

AU - Rudich, S. M.

AU - Bunchman, T. E.

AU - Leichtman, A. B.

AU - Merion, R. M.

AU - Campbell, D. A.

PY - 1999

Y1 - 1999

N2 - The Michigan Kidney Transplant Program has existed for 35 years. Outcomes have improved dramatically as the one-year survival of cadaver kidney grafts increased from 25% to 85-90%. Patient deaths in the first year are now uncommon. Indications for renal transplantation have been extended to infants, the elderly, diabetics and to patients with other significant health problems who would not have been candidates in the past. Chronic administration of large doses of corticosteroids is no longer necessary and the associated morbidity is largely avoided. Improvements in immunosuppression, especially the introduction of cyclosporine, account for much of this progress. With success has come increasing demand. Unfortunately, the gap between the number of available donor kidneys and the number of patients listed for a cadaver transplant continues to increase rather than diminish. Greater acceptance of volunteer donation, as has occurred in our own program, will help to reduce this shortage. If the past forecasts the future, we can anticipate extraordinary advances during the next 35 years.

AB - The Michigan Kidney Transplant Program has existed for 35 years. Outcomes have improved dramatically as the one-year survival of cadaver kidney grafts increased from 25% to 85-90%. Patient deaths in the first year are now uncommon. Indications for renal transplantation have been extended to infants, the elderly, diabetics and to patients with other significant health problems who would not have been candidates in the past. Chronic administration of large doses of corticosteroids is no longer necessary and the associated morbidity is largely avoided. Improvements in immunosuppression, especially the introduction of cyclosporine, account for much of this progress. With success has come increasing demand. Unfortunately, the gap between the number of available donor kidneys and the number of patients listed for a cadaver transplant continues to increase rather than diminish. Greater acceptance of volunteer donation, as has occurred in our own program, will help to reduce this shortage. If the past forecasts the future, we can anticipate extraordinary advances during the next 35 years.

UR - http://www.scopus.com/inward/record.url?scp=0033288337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033288337&partnerID=8YFLogxK

M3 - Article

C2 - 11038632

AN - SCOPUS:0033288337

SP - 139

EP - 148

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -